Pharmaceutical Analysis & Statistics in Norway, April 2015

1-30 of 49 reports

Purchase Reports From Reputable Market Research Publishers

Consumer Health in Norway

Consumer Health in Norway

  • $ 2 394
  • Industry report
  • March 2015
  • by Euromonitor International

Consumer health in Norway continues to develop steadily, displaying marginally stronger growth in 2014 than during the review period. Economic fluctuations and uncertainty did not affect consumer health ...

  • Industries : Drug and Medication
  • Countries : Norway
Norway Pharmaceuticals and Healthcare Report Q2 2015

Norway Pharmaceuticals and Healthcare Report Q2 2015

  • $ 1 300
  • Industry report
  • April 2015
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Norway's epidemiological profile will continue to be attractive to manufacturers of medicines for non-communicable diseases. Despite the relative rapid uptake ...

  • Industries : Pharmaceutical, Healthcare
  • Countries : Norway
Cough, Cold and Allergy (Hay Fever) Remedies in Norway

Cough, Cold and Allergy (Hay Fever) Remedies in Norway

  • $ 898
  • Industry report
  • March 2015
  • by Euromonitor International

Norway, like most other Western countries, experienced a surge in allergies since the first reported incidents in the late 1950s. In the 1970s, allergies were only apparent in fewer than 5% of the population. ...

  • Industries : Drug and Medication
  • Countries : Norway
Digestive Remedies in Norway

Digestive Remedies in Norway

  • $ 898
  • Industry report
  • March 2015
  • by Euromonitor International

Changing lifestyle patterns continued to affect value sales of digestive remedies in 2014. Primarily, Norwegians live more active and hectic lives, combining travel and sports with career and family. Consequently, ...

  • Industries : Drug and Medication
  • Countries : Norway
NRT Smoking Cessation Aids in Norway

NRT Smoking Cessation Aids in Norway

  • $ 898
  • Industry report
  • March 2015
  • by Euromonitor International

NRT smoking cessation aids continued to be highly influenced by the long-standing stringent regulations on tobacco imposed by the Norwegian government. During the review period the total number of smokers ...

  • Industries : Drug and Medication
  • Countries : Norway
Dermatologicals in Norway

Dermatologicals in Norway

  • $ 898
  • Industry report
  • March 2015
  • by Euromonitor International

The summer of 2014 was not only considered long, but also one of the hottest ever. Naturally, the warm weather had a positive impact on the sales of dermatologicals. Topical allergy remedies/antihistamines ...

  • Industries : Drug and Medication
  • Countries : Norway
Vitamins and Dietary Supplements in Norway

Vitamins and Dietary Supplements in Norway

  • $ 898
  • Industry report
  • March 2015
  • by Euromonitor International

A sceptical attitude towards vitamins and dietary supplements among health authorities, doctors and consumers made the importance of health claims essential. However, in order for manufacturers to make ...

  • Industries : Vitamin and Supplement, Vitamin and Supplement
  • Countries : Norway
Weifa AS in Consumer Health (Norway)

Weifa AS in Consumer Health (Norway)

  • $ 153
  • Company report
  • March 2015
  • by Euromonitor International

Weifa is expected to target bigger markets with expansion to other Nordic countries. In Norway, Weifa will facilitate its position in analgesics with further product developments and strategic advertising ...

  • Countries : Norway
Midsona Norge AS in Consumer Health (Norway)

Midsona Norge AS in Consumer Health (Norway)

  • $ 153
  • Company report
  • March 2015
  • by Euromonitor International

The acquisition of the super food company Supernature AS in 2013 and the vitamins and dietary supplements player Nordsveen AS in 2012 showed that Midsona is very interested in establishing itself as a ...

  • Industries : Vitamin and Supplement, Vitamin and Supplement, Healthcare
  • Countries : Norway
Takeda Nycomed AS in Consumer Health (Norway)

Takeda Nycomed AS in Consumer Health (Norway)

  • $ 153
  • Company report
  • March 2015
  • by Euromonitor International

Over the forecast period, Takeda Nycomed will seek to supply Norwegian consumer health with new vitamins and dietary supplements under the well-established Nycomed logo to facilitate its position in c ...

  • Industries : Vitamin and Supplement, Vitamin and Supplement
  • Countries : Norway
Norda ASA

Norda ASA

  • $ 55
  • Company report
  • April 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Norda ASA compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and ...

  • Countries : Norway, United States, World
Photocure ASA

Photocure ASA

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Photocure ASA compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Countries : Norway, United States, World
Norway Pharmaceuticals and Healthcare Report Q1 2015

Norway Pharmaceuticals and Healthcare Report Q1 2015

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: Despite the forecasted decline in the burden of disease in Norway over the next two decades, the anticipated growth of Norway's ageing population is to have an unprecedented impact on the demand ...

  • Industries : Pharmaceutical, Healthcare
  • Countries : Norway
Vitamins & Minerals in Norway (2014) – Market Sizes

Vitamins & Minerals in Norway (2014) – Market Sizes

  • $ 599
  • Industry report
  • December 2014
  • by Mintel

Vitamins & Minerals in Norway by Mintel Market Sizes provides you with annual year-end market size data, most recently updated in 2014. This market covers single/dual, multi-vitamins and minerals. It excludes ...

  • Industries : Retail, Vitamin and Supplement, Vitamin and Supplement
  • Countries : Norway
Drug Stores and Health and Beauty Stores (Retailing) in Norway: Market Snapshot to 2018

Drug Stores and Health and Beauty Stores (Retailing) in Norway: Market Snapshot to 2018

  • $ 75
  • Industry report
  • December 2014
  • by Conlumino

Synopsis Conlumino’s, "Drug Stores and Health and Beauty Stores (Retailing) in Norway: Market Snapshot to 2018" contains detailed historic and forecast retail sales values of Norway Drug Stores and Health ...

  • Industries : Pharmacies and Drug Stores, Pharmacies and Personal Care Stores, Specialty Stores
  • Countries : Norway
Vaccibody AS - Product Pipeline Review - 2014

Vaccibody AS - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Vaccibody AS - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Vaccibody AS - Product Pipeline Review - 2014’, provides an overview of the Vaccibody AS’s pharmaceutical research ...

  • Industries : Biopharmaceutical
  • Countries : Norway
PCI Biotech AS - Product Pipeline Review - 2014

PCI Biotech AS - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

PCI Biotech AS - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘PCI Biotech AS - Product Pipeline Review - 2014’, provides an overview of the PCI Biotech AS’s pharmaceutical research ...

  • Industries : Biotechnology, Pathology
  • Countries : Norway
Lytix Biopharma AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Lytix Biopharma AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Lytix Biopharma AS (Lytix) is a biopharmaceutical company. Its products under clinical development include LTX-109, and LTX-315. The company’s LTX-109 is used for the treatment of melanoma; and ...

  • Industries : Pharmaceutical
  • Countries : Norway
Bionor Pharma ASA - Product Pipeline Review - 2014

Bionor Pharma ASA - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • October 2014
  • by Global Markets Direct

Bionor Pharma ASA - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Bionor Pharma ASA - Product Pipeline Review - 2014’, provides an overview of the Bionor Pharma ASA’s pharmaceutical ...

  • Industries : Biopharmaceutical, Drug and Medication, Pathology, Biotechnology, Research and Development
  • Countries : Norway
Norway Pharmaceuticals and Healthcare Report Q4 2014

Norway Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: While the Norwegian government's pro-generic stance will continue to support growth in the country's off-patent medicines market, we highlight that the loss of market value in the patented drugs ...

  • Industries : Pharmaceutical, Healthcare
  • Countries : Norway
OTC Pharmaceuticals: Scandinavia Industry Guide

OTC Pharmaceuticals: Scandinavia Industry Guide

  • $ 795
  • Industry report
  • October 2014
  • by MarketLine

Introduction The Scandinavian OTC Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to ...

  • Industries : Pharmaceutical, Over-The-Counter Drug
  • Countries : Europe, Norway, Sweden, Denmark
NorDiag ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

NorDiag ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Diagnostics, Diagnostics
  • Countries : United Kingdom, Norway
Algeta ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Algeta ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : Norway, United Kingdom
Navamedic ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Navamedic ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : United Kingdom, Norway
BerGenBio AS - Product Pipeline Review - 2014

BerGenBio AS - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

BerGenBio AS - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘BerGenBio AS - Product Pipeline Review - 2014’, provides an overview of the BerGenBio AS’s pharmaceutical research ...

  • Industries : Research and Development, Pathology
  • Countries : Norway, World
Norway Pharmaceuticals and Healthcare Report Q3 2014

Norway Pharmaceuticals and Healthcare Report Q3 2014

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: An ageing population and the subsequent increased consumption of high-value prescription medicines for the treatment of long-term illnesses will result in rising ...

  • Industries : Pharmaceutical, Healthcare
  • Countries : Norway
Calming and Sleeping in Norway

Calming and Sleeping in Norway

  • $ 898
  • Industry report
  • June 2014
  • by Euromonitor International

As the valerian root was recognised as an herbal remedy with approved medical effects in 2011 by the Norwegian Medicines Agency, the growth rate of calming and sleeping increased. Still, consumers seemed ...

  • Industries : Drug and Medication
  • Countries : Norway
Adult Mouth Care in Norway

Adult Mouth Care in Norway

  • $ 898
  • Industry report
  • June 2014
  • by Euromonitor International

Periodontal diseases are quite significant and the disease affects over 50% of the population and about 5-10% of those risk tooth loss. Smokers and diabetics have a higher risk of being affected. Normally, ...

  • Industries : Drug and Medication
  • Countries : Norway
Analgesics in Norway

Analgesics in Norway

  • $ 898
  • Industry report
  • June 2014
  • by Euromonitor International

A more liberal attitude among youth and young adults and easier access to OTC analgesics was the instrumental fact behind the category’s growth in 2013. Younger people seem to have a lower threshold ...

  • Industries : Drug and Medication
  • Countries : Norway
Apotek 1 Norge AS in Consumer Health (Norway)

Apotek 1 Norge AS in Consumer Health (Norway)

  • $ 153
  • Company report
  • June 2014
  • by Euromonitor International

Apotek 1 Norge AS is expected to expand its coverage of a large pharmacy concept in key areas, with more space for the promotion of other products than just OTC medicine. As a part of a new government ...

  • Industries : Healthcare, Drug and Medication
  • Countries : Norway
About 200 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description

  • February 2015
    3 pages
  • Cancer  

  • United Kingdom  

    Sweden  

    Norway  

View report >

Healthcare Industry

February 2015

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.